IP Library Patent Application 13881201
Patent Application
App. No. 13/881,201

SINGLE UNIT ION EXCHANGE CHROMATOGRAPHY ANTIBODY PURIFICATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/881,201
Abstract

The present invention relates to a method for the purification of antibodies from a protein mixture produced in a bioreactor, at least comprising the steps of intermediate purification and polishing, wherein the intermediate and polishing step comprises in either order in-line anion exchange chromatography (AEX) chromatography and cation exchange chromatography (CEX) chromatography steps in flow-through mode. The present invention further relates to a single operational unit comprising both an anion exchange chromatography part and a cation exchange chromatography part in either order, which are serially connected, wherein the unit comprises an inlet at the upstream end of the first ion exchange chromatography part and an outlet at the downstream end of the second ion exchange chromatography part and wherein the unit also comprises an inlet between the first ion exchange chromatography part and the second ion exchange chromatography part.

Claims (11)

1 - 11 . (canceled)

12 . A method for the purification of antibodies from a cell broth produced in a bioreactor, at least comprising the steps of intermediate purification and polishing, wherein the intermediate purification step comprises combined serially connected in-line anion exchange (AEX) and cation exchange (CEX) chromatography steps in either order, both in flow-through and together operating as one single unit operation, wherein the first chromatography step yields as a flow-through fraction a separation mixture, which is directly subjected to the second chromatography step wherein the second step yields as a flow through fraction a purified antibody preparation, and wherein the purified antibody preparation is subjected to at least one further purification step.

13 . A method according to claim 12 , wherein the AEX chromatography step is carried out first, yielding as a flow-through fraction a separation mixture, serial in-line followed by a CEX chromatography step yielding as a flow-through fraction a purified antibody preparation and wherein the purified antibody preparation is subjected to at least one further purification step.

14 . A method according to claim 12 , wherein the CEX chromatography step is carried out first, yielding as a flow-through fraction a separation mixture, serial in-line followed by a AEX chromatography step yielding as a flow-through fraction a purified antibody preparation and wherein the purified antibody preparation is subjected to at least one further purification step.

15 . Method according to claim 12 , wherein the separation mixture prior to the second ion exchange step is supplemented with an adequate amount of solution in order to adjust the pH and conductivity for optimum performance in the second ion exchange chromatography step.

16 . Method according to claim 13 , wherein the separation mixture prior to CEX chromatography is supplemented with an adequate amount of an acidic solution.

17 . Method according to claim 16 , wherein the separation mixture prior to CEX chromatography is supplemented with an adequate amount of a solution containing citric acid (or its monobasic or dibasic sodium or potassium salts), phosphoric acid (or its monobasic or dibasic sodium or potassium salts), acetic acid, hydrochloric acid or sulfuric acid.

18 . Method according to claim 14 , wherein the separation mixture prior to AEX chromatography is supplemented with an adequate amount of an alkaline solution.

19 . Method according to claim 18 , wherein the separation mixture prior to AEX chromatography is supplemented with an adequate amount of a solution containing sodium or potassium hydroxide, (or its mono or di basic sodium or potassium salts) or tris(hydroxymethyl)aminomethane

20 . A single operational unit which can be used in a method according to claim 13 , comprising both an anion exchange chromatography part and a cation exchange chromatography part, which are serially connected, wherein the outlet of the anion exchange chromatography part is connected to the inlet of the cation exchange chromatography part, wherein the unit comprises an inlet at the upstream end of the anion exchange chromatography part and an outlet at the downstream end of the cation exchange chromatography part and wherein the unit also comprises an inlet between the anion exchange chromatography part and the cation exchange chromatography part.

21 . A single operational unit which can be used in a method according to claim 14 , comprising both an cation exchange chromatography part and a anion exchange chromatography part, which are serially connected, wherein the outlet of the cation exchange chromatography part is connected to the inlet of the anion exchange chromatography part, wherein the unit comprises an inlet at the upstream end of the cation exchange chromatography part and an outlet at the downstream end of the anion exchange chromatography part and wherein the unit also comprises an inlet between the cation exchange chromatography part and the anion exchange chromatography part.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2014
From: DSM IP ASSETS B.V.
To: JLL/DELTA DUTCH NEWCO B.V.
Reel/Frame 034282/0574 →
CHANGE OF NAME Recorded Dec 1, 2014
From: JLL/DELTA DUTCH NEWCO B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0795 →
CHANGE OF ADDRESS Recorded Dec 1, 2014
From: DPX HOLDINGS B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 034500/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2013
From: KREMER, DIDERIK REINDER; DORST, MARIJKE YVONNE
To: DSM IP ASSETS B.V.
Reel/Frame 030800/0981 →